Aprea Therapeutics
APRE
#10568
Rank
A$13.72 M
Marketcap
A$1.11
Share price
6.92%
Change (1 day)
-59.48%
Change (1 year)

Market capitalization of Aprea Therapeutics (APRE)

Market cap: A$13.72 Million

As of June 2026 Aprea Therapeutics has a market cap of A$13.72 Million. This makes Aprea Therapeutics the world's 10568th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aprea Therapeutics from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$13.72 M34.09%
2025A$10.23 M-65.24%
2024A$29.44 M14.23%
2023A$25.77 M-0%
2022A$25.77 M-69.66%
2021A$84.97 M-37.32%
2020A$0.13 B-90.15%
2019A$1.37 B

End of Day market cap according to different sources

On Jun 17th, 2026 the market cap of Aprea Therapeutics was reported to be:

A$13.72 Million
by Nasdaq info icon info icon
A$13.72 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Magellan Health
MGLN
A$3.55 B 25,803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
A$4.72 B 34,296.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
A$2.18 B 15,802.85%๐Ÿ‡บ๐Ÿ‡ธ USA